Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1
Stella Logotheti, Stephan Marquardt, Shailendra K. Gupta, et al.
Theranostics (2020) Vol. 10, Iss. 21, pp. 9620-9643
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 90
H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA‐519d‐3p/lactate dehydrogenase A axis
Linqing Sun, Juntao Li, Wenying Yan, et al.
Cancer Science (2021) Vol. 112, Iss. 6, pp. 2245-2259
Open Access | Times Cited: 68
Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling
Yan Ze Li, Heng Zhu, Yang Du, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 56
Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification
Kanghui Liu, Peng Xu, Jialun Lv, et al.
Oncogene (2023) Vol. 42, Iss. 24, pp. 1980-1993
Closed Access | Times Cited: 36
Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115242-115242
Open Access | Times Cited: 29
Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness
Chao Jing, Yuansheng Duan, Mengqian Zhou, et al.
Theranostics (2021) Vol. 11, Iss. 6, pp. 2655-2669
Open Access | Times Cited: 55
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 44
A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
Yuchen Bai, Qi Zhang, Feng Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208
Jinzhu Han, Xuyi Chen, Jianlong Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 21
LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Shiyi Yu, Ying Wang, Xue Gong, et al.
Cancer Research (2023) Vol. 83, Iss. 19, pp. 3220-3236
Closed Access | Times Cited: 20
ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
Jia Fu, Jin Zhang, Xiya Chen, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 787-809
Open Access | Times Cited: 19
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11
Fenfang Zhou, Zhao Deng, Dexin Shen, et al.
Oncogene (2024) Vol. 43, Iss. 8, pp. 594-607
Closed Access | Times Cited: 8
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
Yuying Zhang, Baoyi Zhu, Minghui He, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 34
The role of noncoding RNAs in metabolic reprogramming of cancer cells
Amir Safi, Mohammadreza Saberiyan, Mohammad‐Javad Sanaei, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 16
E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA
Haoming Shen, Di Zhang, Ping Xiao, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 7, pp. 1007-1017
Open Access | Times Cited: 15
LncRNAs‐circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers
Shanshan Liu, Benzheng Jiao, Hongguang Zhao, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action
Cecilia Pandini, Giulia Pagani, Martina Tassinari, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 6
Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives
Peng Huang, Shaomi Zhu, Xin Liang, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5317-5336
Open Access | Times Cited: 30
The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy
Anup Singh Pathania, Haritha Chava, Ramesh Balusu, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200785-200785
Open Access | Times Cited: 4
Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis
Weiting Kang, Qiang Wang, Yun Dai, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 12
Open Access | Times Cited: 31
Functional roles of antisense enhancer RNA for promoting prostate cancer progression
Chun‐Wu Pan, Simeng Wen, Lei Chen, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1780-1794
Open Access | Times Cited: 30
Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations
Rui Liu, Xiaman Wang, Ying Shen, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 3, pp. 2713-2727
Closed Access | Times Cited: 26
Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond
Stella Logotheti, Christin Richter, Nico Murr, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24
CPT1C-mediated fatty acid oxidation facilitates colorectal cancer cell proliferation and metastasis
Jing Li, Wanwei Zheng, Jie Wu, et al.
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 11
Lactate dehydrogenase B deficiency-dependent hyperlactatemia coordinates with necroptosis to worsen septic liver and kidney injuries
Jia Yu, Chen Qiu, Ge Zhu, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 755, pp. 151552-151552
Closed Access
Page 1 - Next Page

Scroll to top